Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
449.50    4.50 (1.01%)
Bid:
447.50
Ask:
449.00
Spread: 1.50 (0.335%)
Market Cap: £664.06m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Rule 8.3- Creston

8 Oct 2008 10:07

RNS Number : 3475F
AXA Rosenberg Invest. Man.
08 October 2008
Β 

ο»Ώ

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of theΒ Takeover Code)

Β 

1. KEY INFORMATION

Name of person dealing (Note 1)

AXA ROSENBERG INVESTMENT MGT LTD

Company dealt in

CRESTON

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORDINARY

Date of dealing

7/10/08

Β 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

Β 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Β 

Β 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securitiesΒ 

892,866

1.60

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

892,866

1.60

Β 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Β Class of relevant security:

Long

Short

Β 

Number

(%)

Number

(%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Β 

(c) Rights to subscribe (Note 3)

Β 

Class of relevant security:

Details

3. DEALINGS (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/saleΒ 

Number of securities

Price per unit (Note 5)

SOLD

22,000

.45

Β 

(b) Derivatives transactions (other than options)

Β 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Β 

Product

name,Β e.g.

call optionΒ 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

priceΒ 

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5)Β 

Β 

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securitiesΒ 

Exercise price per unit (Note 5)

Β 

(d) Other dealings (including new securities) (Note 4)

Β 

Nature of transaction (Note 8)Β 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)

NO

Β 

Date of disclosure

8/10/08

Contact name

DAVID LEY

Telephone number

0207 895 6744

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETMPBPTMMIMMJP
Date   Source Headline
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024
22nd Jul 20244:51 pmRNSNotice of Results
12th Jul 20246:21 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
12th Jun 202412:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSDirector/PDMR Shareholding
23rd May 20243:26 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSHolding(s) in Company
23rd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
22nd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
17th May 20244:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResult of AGM
15th May 20247:00 amRNSQ1 Trading Update
15th May 20247:00 amRNSDirectorate Change
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.